Treatment of Chronic Bacterial Prostatitis

Evidence Against HBOT

• Guidelines suggest against using HBOT as an adjunctive treatment for bacterial infections, including prostatitis, due to insufficient evidence of clinical benefit, as stated by the Diabetes/Metabolism Research and Reviews 1
• HBOT has significant practical limitations, including high cost, limited availability, and potential side effects, making it impractical as a routine treatment option 2

Recommended Treatment for E. faecalis Prostatitis

• Linezolid 600 mg orally every 12 hours for 2-6 weeks is recommended for chronic bacterial prostatitis caused by E. faecalis, with success rates of 80-86% depending on treatment duration, according to Praxis Medical Insights 3
• Longer treatment durations (4-6 weeks) are associated with higher success rates, as recommended by Praxis Medical Insights 3

Diagnostic Confirmation

• The Meares and Stamey 2- or 4-glass test is essential to confirm chronic bacterial prostatitis and identify E. faecalis as the causative organism, as stated by Praxis Medical Insights 4
• Culture specimens should be taken to determine antimicrobial susceptibility patterns to guide targeted therapy, as recommended by Praxis Medical Insights 4

Monitoring and Adverse Effects

• Weekly complete blood count monitoring is essential during prolonged linezolid therapy (>2 weeks) due to risk of myelosuppression, as stated by Praxis Medical Insights 3
• Drug interactions with serotonergic medications should be carefully assessed, as recommended by Praxis Medical Insights 3